Doctors 2.0 & You and Expanscience Introduce New Preventive Health Short Video Awards Contest

Doctors 2.0 & You4 - 5 June 2015, Paris, France.
United by their mutual commitment to the preservation of health in people everywhere, Doctors 2.0 & You, the international digital health conference and industry partner, Expanscience, an international pharmaceutical and dermo-cosmetics laboratory, invite videomakers to contribute to health prevention promotion by participating in the First Health Prevention Short Video Contest Awards.

Applicants to the contest are invited to produce a short video (up to 120 seconds) that expresses public health messages on one of the two following themes that will benefit from the expertise of Expanscience.

  • How to preserve skin health in babies, teens, pregnant women, and new moms
  • How to prevent osteoarthritis and other rheumatological diseases

According to Doctors 2.0 & You founder Denise Silber, "A short video is an excellent medium to reach and impact a broad audience. We are very pleased to join forces with Expanscience to encourage the production and distribution of great videos and hope that many people will be inspired to help out."

For Jean-Paul Berthomé, CEO of Expanscience, "A brand has more than one dimension and a company as well. At Expanscience we are not just in the business of pharmaceuticals and dermo-cosmetics. Health and prevention are a priority for us. So, it was very natural for us to enter into partnership with Doctors 2.0 & You and reward two video projects, one in the prevention of osteoarthritis and related conditions and the other for the maintenance of healthy skin. We truly hope people around the world will contribute their ideas."

About the Awards Process

  • Contest submissions are open from April 14th, 2015 to May 19th, 2015.
  • The first prize winner in each category (skin health and rheumatology) will receive an award of 2000 euros.
  • The decision will be made by a jury of 7 persons selected for their experience in healthcare and communication.
  • The winner will be announced during the 5th Edition of Doctors 2.0 & You, on June 5, 2015 at Cité Universitaire Paris, France.
  • Videos that respond to the criteria indicated in the complete contest rules online will be displayed on the Doctors 2.0 & You Facebook page during the contest period and through October 31, 2015. The winning videos will be promoted online more broadly.
  • To apply, contestants must fill in the form on the website and submit their video online at http://www.doctors20.com/contests-2/short-video-contest-2015/

For further information, please visit:
http://www.doctors20.com

About Doctors 2.0 & You
Innovative, Insightful, Inspiring, Doctors 2.0 & You is "the must-attend annual digital health conference in Europe". Taking place in Paris, for its fifth edition, on June 4-5, 2015, Doctors 2.0 & You is the only international congress providing a 360° view of state of the art tools and services linking patients and physicians with all other healthcare stakeholders. The conference was founded by Denise Silber, pioneering digital health strategist and influencer.and president of Basil Strategies.

Attendees include patients, professionals, healthcare industries, technologists, payers, government. Key topics in 2015 will include artificial intelligence, augmented reality, 3d printing, connected objects as well as mobile apps, communities, serious games, with examples of deployment in multiple medical conditions. The hashtag #doctors20 is the most tweeted in its category, with nearly 9000 participants to-date.

About Expanscience
In 2014, Expanscience - a French independently-owned pharmaceutical and dermo-cosmetics laboratory - generated turnover of €269.8 million, 46.1% of which was through exports, and employed 967 people. Over more than 60 years, the company has built up a solid international reputation as an innovator and as a specialist in skin and the treatment of arthritis. Its products, which include two leading brands - Piasclédine 300 and Mustela - are sold in more than 97 countries (84 distributing countries and 13 subsidiaries). Expanscience develops and also sells natural-origin active ingredients for use in cosmetics, both in France and abroad. The whole value chain is integrated into the company - from research through to production and distribution. Its CSR policy, which was introduced 10 years ago, was recognised as exemplary by the AFAQ 26000 assessment in 2013.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...